Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

Resveratrol has several beneficial effects, including reductions of oxidative stress, inflammatory responses and apoptosis. It has been known that resveratrol is a sirtuin 1 (SIRT1) activator and protective effects of resveratrol are mediated by Akt and mitogen-activated protein kinases. However, it is not examined whether these pathways are regulated by resveratrol in the ischemic brain. Previously, we found that acute resveratrol treatment reduces brain injury induced by transient focal ischemic stroke. In the present study, we defined the signaling pathways modulated by resveratrol in ischemia by examining SIRT1 expression and phosphorylation of Akt, ERK1/2 and p38 in the ischemic cortex. Resveratrol increased expression of SIRT1 and phosphorylation of Akt and p38 but inhibited the increase in phosphorylation of ERK1/2. Gene and protein levels of peroxisome proliferator-activated receptor γ coactivator 1α, a downstream molecule of SIRT1, and mRNA levels of its target genes antioxidative superoxide dismutase 2 and uncoupling protein 2 were elevated. Resveratrol also increased phosphorylation of cyclic AMP-response-element-binding protein and transcription of the anti-apoptotic gene Bcl-2. These results suggest that various neuroprotective actions of resveratrol, including anti-oxidative, anti-apoptotic and inflammatory effects, are mediated via modulation of multiple signaling pathways in the ischemic brain.

Original languageEnglish
Pages (from-to)2686-2696
Number of pages11
JournalNeurochemical Research
Volume37
Issue number12
DOIs
StatePublished - Dec 2012

Keywords

  • Akt
  • CREB
  • MAPK
  • PGC1a
  • Resveratrol
  • SIRT1

Fingerprint

Dive into the research topics of 'Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain'. Together they form a unique fingerprint.

Cite this